Founded in 1978, The Glaucoma Research Foundation (GRF)is America’s oldest and most experienced national institution dedicated solely to its mission: to prevent vision loss from glaucoma by investing in innovative research, education, and support with the ultimate goal of finding a cure. Glaucoma Research Foundation offers education and support for people and their families through Gleams, a free newsletter providing information about glaucoma treatment and research updates. Gleams is available in print and by e-mail. Additional publications include: Understanding And Living With Glaucoma, a 32 page booklet written by and for people with glaucoma. Childhood Glaucoma, a 32-page reference guide for parents of children with glaucoma.
The Glaucoma Research Foundation (GRF) mission is to prevent vision loss from glaucoma by investing in innovative research, education, and support with the ultimate goal of finding a cure.
GRF funds innovative research and offers education and support for people with glaucoma and their families.
Gleams, a free newsletter with research updates, treatment information, and more, is distributed three times a year in print, and monthly by e-mail.
The GRF website, http://www.glaucoma.org, offers comprehensive glaucoma information and resources including treatment options, low vision and financial assistance resources, and research updates.
GRF publishes the free guidebook, Understanding & Living with Glaucoma, which provides facts and answers for people with glaucoma and their families. An excellent resource for newly diagnosed patients, the guidebook is available in English and Spanish.
Successful research grants funded by the Glaucoma Research Foundation include the Collaborative Normal Tension Glaucoma Study, the first controlled clinical trial to establish that lowering eye pressure preserves vision. Another research grant identified one of the first genes responsible for glaucoma. Today, a major collaborative study, Catalyst For a Cure, is redefining how glaucoma research is conducted. The Catalyst For a Cure research scientists — specialists in genetics, nerve regeneration, and neurodevelopment — work in real-time collaboration to understand neuronal loss in glaucoma and identify new targets for intervention.